7[1]Tsuruo T,Iida H,Tsukagoshi S,et al.4'-O-tetrahydropyranyladriamycin as a potential new antitumor agent[J].Cancer Res,1982,42 (4):1462-1467.
8[7]Herait P,Poutignat N,Marty M,et al.Early assessment of a new anticancer drug analogue are the historical comparisons obsolete-The French Experience with Pirarubicin[J].Eur J Cancer,1992,28A:1670-1676.
9[8]Okuma K,Furuta I,Ota K.Acute cardiotoxicity of antharacyclines-analysis by using holter ECG[J].J Cancer Chemother,1984,11 (4):901-905.
10[9]Tsutsumi Y,Kawamura T,Saitoh S,et al.Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with chemotherapy and rituximab:necessity of prophylaxis for hepatitis B virus reactivation in rituximab therapy[J].Leuk Lymphoma,2004,45 (3):627-629.
